Datavault AI Inc. Announces Issuance of Two Foundational U.S. Patents Advancing Blockchain-Driven Content Licensing and Tokenized MonetizationStrengthens Datavault AI’s Leadership in AI-Powered Data Valuation and Real-World Asset (RWA) Tokenization Across Multi-Trillion Dollar Markets
Director/PDMR ShareholdingThe Magnum Ice Cream Company N.V.
Meximodo Tequila Announces Launch of Meximodo Tequila Blanco, a Woman-Led Organic Tequila BrandJersey City, NJ, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Meximodo Tequila announced the launch of Meximodo Tequila Blanco, a premium organic tequila introduced by entrepreneur Mehak Abrol, Founder and Chief Executive Officer of Meximodo Tequila. The announcement marks the company’s inaugural product release and establishes Meximodo Tequila as a woman-led entrant into the premium spirits category.
ArcelorMittal expands its portfolio of renewable energy projectsThree new projects in India will bring the Company’s global renewable energy capacity to 3.3GW
A.P. Moller Capital announces Indian renewables investment with Rays Power InfraCOPENHAGEN, Denmark, Dec. 22, 2025 (GLOBE NEWSWIRE) -- A.P. Moller Capital, an institutional fund manager investing globally in critical infrastructure, has announced an investment through the A.P. Moller Capital - Emerging Markets Infrastructure Fund II in an Indian renewables joint venture with Rays Power Infra Limited (“Rays Power Infra”), a leading solar engineering, procurement and construction provider. The partnership will develop large-scale renewable projects across India, with the initial projects currently under development expected to reach a combined capacity of around 900 MW.
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz PharmaREYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (
NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that launches are underway in Europe for Gobivaz® (golimumab), Alvotech’s biosimilar to Simponi® (golimumab), also known as AVT05 (prefilled syringe and autoinjector). Gobivaz is the first marketed biosimilar to Simponi worldwide. It is being commercialized exclusively in Europe by Alvotech’s partner, Advanz Pharma Holdco Limited (“Advanz Pharma”).
THEON concludes a transformative 2025THEON concludes a transformative 2025
AMG Lithium Receives Funding from German Federal Ministry for Economic Affairs and EnergyAmsterdam, 22 December 2025 --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) subsidiary AMG Lithium GmbH (“AMG Lithium”) is in the qualification phase before full commercial production at its lithium hydroxide refinery in Bitterfeld, Germany. After having completed ongoing customer testing of factory samples, the site will be the first industrial-scale battery-grade lithium hydroxide production facility in Europe, and by mid-2026 will operate at design capacity.
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugatePARIS, FRANCE; 22 DECEMBER 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today an exclusive licensing agreement for global rights outside of Greater China, for SIM0613, an antibody-drug conjugate (ADC) with best-in-class potential. Targeting the LRRC15 protein, SIM0613 is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
WISeKey Issues Year-End CEO Letter to ShareholdersGeneva, Switzerland, December 22, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today issued a Letter to Shareholders by its Founder and CEO, Carlos Moreira.
HYCU® Partners with VSTECS as Regional Distributor to Accelerate Modern Data Protection Across Asia-PacificDistribution Agreement Expands Access to HYCU R-Cloud™ Through VSTECS’ Extensive Channel Network in Singapore, Indonesia, Philippines, Thailand, and Malaysia
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA ResubmissionsMELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides a precision medicine portfolio update in relation to:
Important Notice to Long-Term Shareholders of Holley Inc. (NYSE: HLLY) F/K/A Empower Ltd.: Grabar Law Office Investigates Claims on Your Behalf After Securities Fraud Class Action Complaint Survives Motion to DismissPHILADELPHIA, Dec. 21, 2025 (GLOBE NEWSWIRE) -- Current Holley Inc. (
NYSE: HLLY) shareholders who have held Holley shares since on or shortly after July 21, 2021, or via holdings of Empower Ltd. (a SPAC), can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/holley-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.
Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission SuccessMAHIA, New Zealand, Dec. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its 21st Electron rocket of the year to deploy the latest satellite to space for multi-launch customer Institute for Q-shu Pioneers of Space, Inc. (iQPS), a Japan-based Earth imaging company.
Tallulah Films Partners with Fresh Patch to Launch Story-Driven Branded Content in 2026Independent production company and leading pet-brand pioneer join forces to redefine branded entertainment through emerging media.
Copyseeker Launches n8n Community Node for Automated Reverse Image SearchIf you've ever tried to track down where your images end up online, you know it's a nightmare. Manual searching takes forever, and you're bound to miss stuff. That's the problem Copyseeker set out to solve—and today, it just got a whole lot easier with the release of an official n8n community node.
Hunger Strike By Inmate Protesting Racial Segregation of Blacks in Maricopa County 4th Avenue Jail Enters Third WeekPHOENIX, Dec. 20, 2025 (GLOBE NEWSWIRE) -- Gary Green, one of several inmates represented by Comeback Law PC, who legally challenged the racial segregation of Blacks in Sheriff Jerry Sheridan’s 4th Avenue Jail in October, is now in the third week of a hunger strike protesting retaliation against him by Sheriff Sheridan.
The 3D-Flow Architecture Breakthrough: A Universal, Scalable Digital Processor for Real-Time Pattern Recognition in High-Rate Data Streams — A Platform to Save Millions of Lives and Billions of EurosA Revolutionary ATCA/VME/VXI 3D-Flow Board: 512 Channels, >2,800 Programmable Operations—Scalable to >50,000 Operations on Each Dataset Arriving Every 25 ns with Zero Data Loss at a fraction of the cost of FPGA <100 operations per dataset
JAMES HARDIE CLASS ACTION DEADLINE 12/23: Bragar Eagel & Squire, P.C. Reminds James Hardie Industries Investors to Contact the Firm Regarding Their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options
INSP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Inspire Medical Systems Investors Have Opportunity to Lead Class Action LawsuitFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
OWL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue Owl CapitalFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blue Owl To Contact Him Directly To Discuss Their Options
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi TherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options
NJDCY SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NidecFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options
KMX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that CarMax Investors Have Opportunity to Lead Class Action LawsuitFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their Options
JHX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that James Hardie Investors Have Opportunity to Lead Class Action LawsuitFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In James Hardie To Contact Him Directly To Discuss Their Options
BTDR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bitdeer TechnologiesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bitdeer To Contact Him Directly To Discuss Their Options
SKYE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye BioscienceFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options
DEFT SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DeFi TechnologiesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DeFi Technologies To Contact Him Directly To Discuss Their Options
SFM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sprouts Farmers MarketFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sprouts To Contact Him Directly To Discuss Their Options
Particula Selected To Co-Structure RFP and Provide Independent Ratings for Keel's $500M Regatta ProgramParticula, the leading rating provider for digital assets, today announced its collaboration with Kinetika Research on the 500M Keel Solana Tokenization Regatta
Intercont (Cayman) Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyHONG KONG, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Intercont (Cayman) Limited (“NCT”, the “Company”, or “we”) (
NASDAQ: NCT), a global carbon-neutral shipping company, today announced that, on December 15, 2025, the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). The Notification Letter is based upon the fact that the closing bid price of the Company’s ordinary shares (“Ordinary Shares”) was below $1.00 per share for a period of 30 consecutive business days from October 31, 2025 to December 12, 2025.
Ero Files Technical Report for the Xavantina OperationsVANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) is pleased to announce the filing of its Technical Report for the Xavantina Operations related to the update on its National Instrument 43-101 compliant mineral reserve and resource estimate previously announced on November 4, 2025.
Launchpad Cadenza Acquisition Corp I Completes $230,000,000 Initial Public OfferingNew York, NY, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Launchpad Cadenza Acquisition Corp I (the “Company”) announced today the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000. The Company’s units began trading on December 18, 2025 on The Nasdaq Global Stock Market LLC (“Nasdaq”) under the ticker symbol “LPCVU.” Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share, subject to certain adjustment. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “LPCV” and “LPCVW,” respectively. Of the proceeds received from the consummation of the initial public offering (including the exercise of the over-allotment option) and a simultaneous private placement of warrants, $230,000,000 (or $10.00 per unit sold in the offering) was placed in trust.
Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of SchwazzeMINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it plans to acquire additional outstanding senior secured convertible notes (the “Notes”) of Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. Total outstanding principal plus accrued interest of the acquired Notes is approximately $2.6 million, but the Notes will be acquired at a substantial discount to par value for total consideration of approximately $1.6 million payable in subordinate voting shares of the Company at closing at a price per share of $0.54.
NCLA Asks Third Circuit to Toss Pennsylvania, N.J. Suit Seeking to Empower Fed. Agencies to LegislateCommonwealth of Pennsylvania, et al. v. President of the United States, Little Sisters of the Poor Saints Peter and Paul Home, et al.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on December 18, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 43,150 shares of Iovance’s common stock to four new, non-executive employees.
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SECSAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) announced today that it will be rescheduling its upcoming special meeting of shareholders, originally scheduled to be held on January 16, 2026 (the “Meeting”), to a later date to be announced. Aptose will hold the rescheduled Meeting as soon as practicable in January 2026. No changes are expected to be made to the record date of the Meeting, being the close of business on December 12, 2025, or to the matters to be put before shareholders at the Meeting, including the previously announced continuance of Aptose from the Canada Business Corporations Act to the Business Corporations Act (Alberta) (“ABCA”) (the “Continuance”) and the subsequent acquisition by HS North America Ltd., a wholly owned subsidiary of Hanmi Pharmaceutical Co. Ltd. (together, the “Hanmi Purchasers”), by way of a statutory plan of arrangement under the ABCA (the “Arrangement” and, together with the Continuance, the “Transaction”).
CN Statement on UP-NS STB FilingMONTREAL, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The application filed this morning by Union Pacific and Norfolk Southern fails to demonstrate that the merger would enhance competition or generate significant public benefits that would require a merger. It falls well below both the 2001 and old merger rules set out by the Surface Transportation Board (STB).
Life360 Moves to Invalidate Patent at Center of GoCodes AccusationsFiling underscores Life360’s commitment to confronting weak or coercive claims through direct legal challenges
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma SharesTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (
NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.
PIMCO Closed-End Fund Declares Supplemental Year-End DistributionNEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of the PIMCO closed-end fund below (the “Fund”) has declared a supplemental year-end distribution for the Fund’s common shares as summarized below. The distribution is payable on January 13, 2026 to shareholders of record on December 29, 2025, with an ex-dividend date of December 29, 2025. In addition to the regular monthly dividends, this supplemental year-end distribution is being paid to allow the Fund to meet its 2025 distribution requirements for federal excise tax purposes. The Fund’s total distributions will be taxable to shareholders in 2025.
National Healthcare Properties Announces Preferred Stock DividendsNEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, NHP declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock payable on January 15, 2026 to holders of record at the close of business on January 2, 2026. In addition, NHP declared a dividend of $0.4453125 per share on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock payable on January 15, 2026 to holders of record at the close of business on January 2, 2026.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 13,144 restricted stock units of the company’s common stock to nine newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of December 17, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Arkansas selected to lead national manufacturing apprenticeship expansion effortLITTLE ROCK, Ark., Dec. 19, 2025 (GLOBE NEWSWIRE) -- The State of Arkansas has been awarded a four-year, $35.8 million cooperative agreement from the U.S. Department of Labor to lead a nationwide expansion of registered apprenticeship programs in advanced manufacturing through the newly established American Manufacturing Apprenticeship Incentive Fund.
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on December 15, 2025 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase 300,000 shares of the Company’s common stock to two newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
Rocket Lab Awarded $816M Prime Contract to Build Missile- Defense Satellite Constellation for U.S. Space ForceRocket Lab’s largest contract to date solidifies its position as a disruptive force in national security space, redefining the speed and efficiency of satellite production and challenging legacy aerospace primes
Lifeward Appoints Bob Marshall as Chairman of the BoardMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that its Board of Directors has appointed Bob Marshall as Chairman of the Board, effective January 1, 2026. He replaces Joseph Turk, who will transition off the Board in connection with his new position at Fresenius Medical Care.
Nyxoah Announces Issuance of First Tranche of Convertible BondsNyxoah Announces Issuance of First Tranche of Convertible Bonds
Vine Hill Capital Investment Corp. II Announces Closing of Upsized $230 Million Initial Public OfferingFort Lauderdale, Florida, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. II (the “Company”), a special purpose acquisition company, today announced the closing of its upsized initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “VHCPU” on December 18, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be traded on Nasdaq under the symbols “VHCP” and “VHCPW,’’ respectively.
Solidifi Successfully Completes Its First UAD 3.6 Order, Marking a Major Milestone in Appraisal ModernizationBUFFALO, N.Y., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Solidifi, one of the largest appraisal management companies in the United States, today announced the successful completion of its first Uniform Appraisal Dataset (UAD) 3.6 order, marking a significant achievement in the company’s readiness for the appraisal modernization initiative led by Fannie Mae and Freddie Mac.
VinceTrust launches Christmas event contracts to help mainstream cryptocurrencies continue to grow in valueWith Christmas approaching, the global digital asset market is experiencing a year-end surge in attention. Digital asset management platform Vince Trust recently announced the official launch of a special Christmas reward campaign, offering a limited-time registration incentive program for new users worldwide.
Bombardier Global 8000, World’s Fastest Business Jet, Receives U.S. Federal Aviation Administration (FAA) CertificationMONTREAL, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Bombardier today announced that the Global 8000(1), the world’s fastest business aircraft, received U.S. Federal Aviation Administration (FAA) certification. The FAA certification marks the latest in a series of achievements over the past year that continue to illustrate the exceptional pedigree of this industry-defining ultra-long-range business aircraft – the fastest and most luxurious business jet in the skies. The Global 8000 received Transport Canada Type Certification on November 5, 2025 and entered into service in December 2025. Certification from the European Union Aviation Safety Agency (EASA) is pending.
Transaction in Own SharesTransaction in Own Shares
Morgan & Morgan Announces Record-Breaking Year Of AwardsORLANDO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- National plaintiff’s law firm Morgan & Morgan announced that the firm and its attorneys were recognized with hundreds of honors from legal and business publications in 2025 for their impactful, cutting-edge work on behalf of consumers, workers and the injured across the United States.
